雜志介紹

Annals Of Translational Medicine雜志介紹

《Annals Of Translational Medicine》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱轉(zhuǎn)化醫(yī)學(xué)年鑒，本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• EML4-ALK rearrangement of lung large cell neuroendocrine carcinoma: a case report

  Author: Chen, Dianjun; Ma, Shuangyue; Sun, Lili; Lang, Yuehong; Yang, Boyan

• A pan-cancer analysis of the expression and prognostic significance of PDRG1

  Author: Liu, Zhen; Huang, Ketuan; He, Yongfei; Hao, Shuqing; Wei, Zhongliu; Peng, Tao

• Research progress and clinical evaluation of histotripsy: a narrative review

  Author: Li, Shuaiqi; Wei, Yufan; Zhang, Boya; Li, Xiru

• Peroxiredoxin 6 alleviates high glucose-induced inflammation and apoptosis in HK-2 cells by inhibiting TLR4/NF-Kappa B signaling

  Author: Wu, Hao; Wu, Rong; Liu, Tianxi; Ma, Hongbin; Xue, Guozhong; Liu, Minglong

英文介紹

Annals Of Translational Medicine雜志英文介紹

Annals Of Translational Medicine was founded in 2013 and is published bimonthly by the domestic AME Publishing Company group. and observational research, aiming to publish the most practical and up-to-date information in medical research, thereby broadening readers' horizons and promoting the translation between research theory and clinical application. 

The editor-in-chief of the journal includes Professor Wang Xuehao (Academician of the Chinese Academy of Engineering), Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Professor Sun Yinghao (Academician, Chinese Academy of Engineering), Department of Urology, Changhai Hospital, Naval Medical University, and Professor Calvin S. H. Ng, Prince of Wales Hospital, Chinese University of Hong Kong.